The role of adapter protein Shc in estrogen non-genomic action

Steroids

Volumn 69, Issue 8-9, 2004, Pages 523-529

  Zhang, Zhenguo ^a   Kumar, Rakesh ^b   Santen, Richard J ^a   Song, Robert X D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer cells; ER ; MAP kinase; Shc; Steroid

Indexed keywords

ADAPTOR PROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SHC;

AMINO TERMINAL SEQUENCE; APOPTOSIS; BREAST CANCER; CANCER RESEARCH; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONFERENCE PAPER; CYTOSOL; DRUG RESEARCH; DRUG TARGETING; ENZYME ACTIVITY; ENZYME REGULATION; GENOME; HUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CELL MEMBRANE; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES;

MINK CELL FOCUS-FORMING VIRUS;

EID: 3543020345     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2004.05.012     Document Type: Conference Paper

References (41)

1. Watson C.S., Norfleet A.M., Pappas T.C., Gametchu B. Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-alpha. Steroids. 64:1999;5-13
2. Migliaccio A., Di Domenico M., Castoria G., de Falco A., Bontempo P., Nola E., et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1996;1292-1300
3. Sun M., Paciga J.E., Feldman R.I., Yuan Z., Coppola D., Lu Y.Y., et al. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer. Cancer Res. 61:2001;5985-5991
4. Kahlert S., Nuedling S., van Eickels M., Vetter H., Meyer R., Grohe C. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 275:2000;18447-18453
5. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14:2000;1649-1660
6. Stefano G.B., Prevot V., Beauvillain J.C., Cadet P., Fimiani C., Welters I., et al. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation. 101:2000;1594-1597
7. Stefano G.B., Cadet P., Breton C., Goumon Y., Prevot V., Dessaint J.P., et al. Estradiol-stimulated nitric oxide release in human granulocytes is dependent on intracellular calcium transients: evidence of a cell surface estrogen receptor. Blood. 95:2000;3951-3958
8. Song R.X., McPherson R.A., Adam L., Bao Y., Shupnik M., Kumar R., et al. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. Mol. Endocrinol. 16:2002;116-127
9. Kousteni S., Bellido T., Plotkin L.I., O'Brien C.A., Bodenner D.L., Han L., et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 104:2001;719-730
10. Marquez D.C., Pietras R.J. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene. 20:2001;5420-5430
11. Bression D., Michard M., Le Dafniet M., Pagesy P., Peillon F. Evidence for a specific estradiol binding site on rat pituitary membranes. Endocrinology. 119:1986;1048-1051
12. Brubaker K.D., Gay C.V. Specific binding of estrogen to osteoclast surfaces. Biochem. Biophys. Res. Commun. 200:1994;899-907
13. Norfleet A.M., Clarke C.H., Gametchu B., Watson C.S. Antibodies to the estrogen receptor-alpha modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors. FASEB J. 14:2000;157-165
14. Improta-Brears T., Whorton A.R., Codazzi F., York J.D., Meyer T., McDonnell D.P. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc. Natl. Acad. Sci. USA. 96:1999;4686-4691
15. Razandi M., Pedram A., Levin E.R. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol. Endocrinol. 14:2000;1434-1447
16. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., de Falco A., Lombardi M., et al. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20:2001;6050-6059
17. Katzenellenbogen B.S., Montano M.M., Ediger T.R., Sun J., Ekena K., Lazennec G., et al. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog. Horm. Res. 55:2000;163-193
18. Ylikomi T., Bocquel M.T., Berry M., Gronemeyer H., Chambon P. Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J. 11:1992;3681-3694
19. Katzenellenbogen J.A., O'Malley B.W., Katzenellenbogen B.S. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10:1996;119-131
20. Song RX, Kumar R. The role of adapter proteins in ER alpha membrane association and function. In: Watson CS, editor. The identities of membrane steroid receptors. Boston, Dordrecht, London: Kluwer Academic Publishers; 2003. p. 67-76.
21. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 407:2000;538-541
22. Migliaccio E., Giorgio M., Mele S., Pelicci G., Reboldi P., Pandolfi P.P., et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature. 402:1999;309-313
23. Ravichandran K.S. Signaling via Shc family adapter proteins. Oncogene. 20:2001;6322-6330
24. Pelicci G., Dente L., De Giuseppe A., Verducci-Galletti B., Giuli S., Mele S., et al. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. Oncogene. 13:1996;633-641
25. Pelicci G., Lanfrancone L., Salcini A.E., Romano A., Mele S., Grazia B.M., et al. Constitutive phosphorylation of Shc proteins in human tumors. Oncogene. 11:1995;899-907
26. Rozakis-Adcock M., McGlade J., Mbamalu G., Pelicci G., Daly R., Li W., et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 360:1992;689-692
27. Boney C.M., Gruppuso P.A., Faris R.A., Frackelton A.R. Jr. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes. Mol. Endocrinol. 14:2000;805-813
28. Hubbard S.R., Till J.H. Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69:2000;373-398
29. Superti-Furga G., Courtneidge S.A. Structure-function relationships in Src family and related protein tyrosine kinases. Bioessays. 17:1995;321-330
30. Superti-Furga G. Regulation of the Src protein tyrosine kinase. FEBS Lett. 369:1995;62-66
31. Vanhaesebroeck B., Waterfield M.D. Signaling by distinct classes of phosphoinositide 3-kinases. Exp. Cell Res. 253:1999;239-254
32. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70:2001;535-602
33. Lamothe B., Bucchini D., Jami J., Joshi R.L. Interaction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system. FEBS Lett. 373:1995;51-55
34. Altschuler D., Yamamoto K., Lapetina E.G. Insulin-like growth factor-1-mediated association of p85 phosphatidylinositol 3-kinase with pp 185: requirement of SH2 domains for in vivo interaction. Mol. Endocrinol. 8:1994;1139-1146
35. Yamamoto K., Altschuler D., Wood E., Horlick K., Jacobs S., Lapetina E.G. Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85. J. Biol. Chem. 267:1992;11337-11343
36. Shioi T., McMullen J.R., Kang P.M., Douglas P.S., Obata T., Franke T.F., et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell Biol. 22:2002;2799-2809
37. Fry M.J. Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play? Breast Cancer Res. 3:2001;304-312
38. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M., et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17:1998;2008-2018
39. Nethrapalli I.S., Singh M., Guan X., Guo Q., Lubahn D.B., Korach K.S., et al. Estradiol (E2) elicits SRC phosphorylation in the mouse neocortex: the initial event in E2 activation of the MAPK cascade? Endocrinology. 142:2001;5145-5148
40. Boonyaratanakornkit V., Scott M.P., Ribon V., Sherman L., Anderson S.M., Maller J.L., et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell. 8:2001;269-280
41. Adam L., Vadlamudi R., Kondapaka S.B., Chernoff J., Mendelsohn J., Kumar R. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J. Biol. Chem. 273:1998;28238-28246